Abstract
Benign metastasizing leiomyoma (BML) is a rare disease that results from metastasis of uterine leiomyoma to distant sites with benign pathologic features. The lung is the most common metastatic site for BML. This report describes the case of a 49-year-old woman who presented with a mass in the abdominal wall with a surgical history of uterine myomectomy. Ultrasound and Magnetic resonance imaging (MRI) revealed multiple mass lesions. The histopathology of the mass specimen indicated BML. The imaging and clinical features of BML are discussed based on the characteristics of this case and related literature reports.
Introduction
BML is a rare disease, first described by Steiner in 1939 (). Although the disease appears benign in histomorphology, the biological behavior of the tumor is invasive. The most commonly involved organ is the lung, and others include lymph nodes, heart, skeletal muscle and pelvic cavity (–). BML is usually associated with a history of hysterectomy or myomectomy (). A patient with BML in the abdominal wall is described in this study.
Case presentation
A 49-year-old woman, gravida 1 para 1, accidentally presented with an egg-sized abdominal mass. Symptoms of fever, abdominal pain, and weight loss were not present, and she had previously undergone myomectomy. Physical examination revealed a rigid mass, with moderate motion and no tenderness.
Ultrasound examination showed multiple hypoechoic masses in the subcutaneous fascia layer. The two larger ones are approximately 41 x 25mm and 20 x 16mm with clear boundaries that were connected (Figure 1A). Color Doppler flow imaging (CDFI) showed a punctate blood flow signal within the mass (Figure 1B), and resistance index of 0.74. Contrast-enhanced ultrasound (CEUS) was performed using the contrast agent SonoVue. Simultaneously, an ultrasound-guided abdominal wall mass core needle biopsy was performed on the two masses. The larger mass showed relatively high enhancement in both arterial and venous phases. The smaller mass showed relatively no enhancement in the arterial phase and low enhancement around in venous phase (Figure 1C). An MRI was performed, which showed similar circular abnormal signal shadows on the anterior abdominal wall and abdominal cavity, with sizes of 29 x 16mm and 31 x 21mm, a slightly longer T1 and slightly longer T2, limited diffusion, and progressive enhancement after enhancement (Figures 2A–F). Chest Computed Tomography (CT) examination showed no abnormality. CEA, AFP, CA724, CA199 and CA125 markers were all normal.
Figure 1
Figure 2
Pathology of the biopsy suggested a spindle cell tumor, and combined with the patient’s surgical history, a fibromatosis in the abdominal wall was considered. The patient underwent the elective resection of the abdominal wall and abdominal cavity tumors. Two masses of 4 x 3cm and 2 x 2cm were observed during the operation, the larger one protruding into the abdominal cavity and the smaller one located in the anterior sheath of the rectus muscle. Two masses, about 2/3 of the rectus abdominis muscle and part of the posterior sheath, were removed completely. The surgeon performed tension-free repair of an abdominal wall hernia, inserting the patch into the abdominal cavity under the incision, fixing it on the abdominal wall, and suturing the rectus abdominis muscle and anterior sheath of the rectus abdominis muscle.
The histopathological examination showed spindle cells. Immunohistochemical staining showed that smooth muscle actin (SMA), desmin, estrogen receptor (ER) and progesterone receptor (PR) were positive, and cell proliferation antigen Ki-67 was less than 1% (Figures 3A–F). Based on these findings, the tumor was diagnosed as BML.
Figure 3
Discussion
The mechanism of BML has been reported in various reports and remains controversial. Most instances of BML occur after uterine myomectomy or hysterectomy. The mechanism may be that surgery increases surgically induced hematogenous spread. In this case, iatrogenic peritoneal seeding theory seems to be a more reasonable explanation for the occurrence of BML (, ). Immunohistochemistry showed that ER and PR of tumor cells were positive, suggesting that BML may also be induced by hormone stimulation. Chromosomal abnormalities such as 19q, 22q, 1p, 13q deletion and 6p21 rearrangement can be found in these tumors (). Other possible mechanisms include mesothelial metaplasia and misdiagnosed low-grade uterine leiomyosarcoma metastasis ().
The clinical symptoms of BML are related to the affected sites. The most common site of metastasis is the lung, and the patients have no obvious clinical manifestations in the early stage, with a few having cough, chest pain, dyspnea and other symptoms (, ). In patients with BML involving the spine, leg pain and paresthesia have been reported (). Patients with metastasis to the femur and muscles may have difficulty walking (). BML involving the uterus, heart, and lymph nodes may be asymptomatic. Multiple abdominal wall metastases are rare, as reported in this case. BML with abdominal wall metastases has been reported in the literature (Table 1). Although most cases of BML occur following myomectomy or hysterectomy, some cases of BML are not related to prior surgical history (). Studies have shown that BML can occur in premenopausal or postmenopausal women, and up to 30% of cases may have respiratory symptoms ().
Table 1
| Metastasis | Age | History of gynecologic surgery | Surgical treatment |
|---|---|---|---|
| abdominal wall and pelvic cavity | 37 () | myomectomy 10 years earlier | extirpation of the abdominal and pelvic tumors and partial greater omentum |
| abdominal wall and pelvic cavity | 46 () | hysterectomy 8 years earlier | extirpation of the abdominal and pelvic tumors and bilateral oophorectomy |
| abdominal wall and pulmonary | 33 () | myomectomy 13 years earlier | extirpation partial tumors |
| abdominal wall | 42 () | mysterectomy 8 years earlier | extirpation of the tumors |
| abdominal wall | 44 () | hysterectomy | extirpation of the tumors |
| abdominal wall and pulmonary | 44 () | myomectomy | N/A |
| abdominal wall and pelvic cavity | 49 () | myomectomy 12 years earlier | N/A |
| abdominal wall, pelvic cavity and pulmonary | 47 () | twice myomectomy and hysterectomy | N/A |
| abdominal wall and pulmonary | 44 () | myomectomy and abdominal hysterectomy | extirpation of the tumors in pulmonary |
| multiple metastasis (abdominal wall, ventricle wall, lungs, liver, muscles, and pelvic cavity) | 37 () | twice myomectomy | hysterectomy and resection of the nodules in the mesosalpinx, mesenterium, and abdominal wall |
| abdominal wall, abdominal and pelvic cavity | 54 () | abdominal hysterectomy and bilateral salpingo-oophorectomy 6 years earlier | extirpation of the tumors |
Summary of BML cases with abdominal wall metastasis.
BML is radiographically characterized as a benign mass. On ultrasound, BML can be manifested as multiple hypoechoic masses in the abdominal wall or pelvic cavity, and blood flow signals can be seen inside. It can be shown as multiple nodules with clear boundaries on CT, with no significant enhancement on enhanced CT (). Notably, fluorodeoxyglucose (FDG) -positron emission tomography (PET)/CT showed that FDG uptake by tumors was all within the physiological range (). According to the review of the FDG-PET/CT examination results of BML, the FDG uptake level of more than 90% of BML patients is lower than the medium level (), which can be used as one of the crucial bases for the differentiation of benign and malignant tumors. Therefore, physicians must maintain heightened awareness and index of suspicion when approaching a woman with a mass in any region of the abdomen or pelvis. Further investigation with abdominal and pelvic ultrasonography and magnetic resonance imaging or computed tomography is necessary. Benign lesions can be found even in patients presenting with giant masses and higher CA125 than normal levels (). CA125 and CA199 are considered to be important gynecological tumor indicators, which are commonly seen in malignant tumor diseases, and their elevated levels do not represent absolute malignancy (, ).
Regarding pathological diagnostic criteria for BML, BML presents as an extra-uterine smooth muscle cell proliferation with histological features similar to those of primary benign uterine fibroids. Uterine leiomyoblastoma can also exhibit some malignant features, making it difficult for physicians to distinguish (). Immunohistochemistry is also very helpful in differentiating leiomyoma from leiomyosarcoma. Studies have shown that the positive rate of ER/PR in MBL patients is over 90%, and only 4.4% are negative at the same time (). ER/PR positivity is specific for uterine leiomyomas and may be helpful in diagnosing BML. In the present case, the abdominal mass was excised, and immunohistochemistry confirmed that the patient’s ER/PR was positive.
There is currently no standardized treatment for BML. Due to the behavioral characteristics of the slow growth of BML, most lesions do not change in size after long-term follow-up, and regular follow-up and periodic imaging examinations can be chosen. Since BML can be hormone-dependent (ER and PR-positive), hormone therapy such as GnRH-a, progesterone antagonists (Mifepristone), selective estrogen receptor modulators (SERMs, tamoxifen) and aromatase inhibitors may be considered, or even surgery to remove the ovaries, particularly for patients with symptomatic lung involvement (, , ). Although bilateral oophorectomy is commonly used, unilateral oophorectomy is sufficient to promote the reduction of lung BML mass (). In addition, surgical removal of the tumor is an effective treatment.
Conclusion
The characteristics of low specificity and incidence rate of BML can lead physicians to be unfamiliar with the disease, enabling it to be misdiagnosed as a malignant tumor. Asking operation history of myomectomy or hysterectomy can help us diagnose BML. Pathological diagnosis plays an essential role in determining the follow-up treatment. Obtaining part of the specimens through ultrasound-guided tissue core needle biopsy is effective and safe and can be used as one of the recommended methods.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.
Ethics statement
Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
JH: Writing – original draft. ST: Writing – review & editing. QP: Writing – review & editing. YY: Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
SteinerPE. Metastasizing fibroleiomyoma of the uterus: report of a case and review of the literature. Am J Pathol. (1939) 15:89–110.
2
Pacheco-RodriguezGTaveira-DaSilvaAMMossJ. Benign metastasizing leiomyoma. Clin Chest Med. (2016) 37:589–95. doi: 10.1016/j.ccm.2016.04.019
3
LiuYLiDLiXWangJWangJ. Benign metastasizing leiomyoma: is “Wait and watch” Strategy feasible? Reprod Sci. (2023) 30:3568–77. doi: 10.1007/s43032-023-01314-9
4
KarnibMRheaIElliottRChakravartySAl-KindiSG. Benign metastasizing leiomyoma in the heart of a 45-year-old woman. Tex Heart Inst J. (2021) 48:e197066. doi: 10.14503/THIJ-19-7066
5
HurJWLeeSLeeJBChoTHParkJY. What are MRI findings of spine benign metastasizing leiomyoma? Case report with literature review. Eur Spine J. (2015) 24 Suppl 4:S600–5. doi: 10.1007/s00586-015-3774-8
6
BeckMMBiswasBD’SouzaAKumarR. Benign metastasising leiomyoma after hysterectomy and bilateral salpingo-oophorectomy. Hong Kong Med J. (2012) 18:153–5
7
CucinellaGGraneseRCalagnaGSomiglianaEPerinoA. Parasitic Myomas after Laparoscopic Surgery: An Emerging Complication in the use of Morcellator? Description of Four Cases. Fertil Steril. (2011) 96:e90–6. doi: 10.1016/j.fertnstert.2011.05.095
8
BowenJMCatesJMKashSItaniDGonzalezAHuangDet al. Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis. Cancer Genet. (2012) 205:249–54. doi: 10.1016/j.cancergen.2012.04.005
9
AwonugaAORotasMImudiaANChoiCKhulpateeaN. Recurrent benign metastasizing leiomyoma after hysterectomy and bilateral salpingo-oophorectomy. Arch Gynecol Obstet. (2008) 278:373–6. doi: 10.1007/s00404-008-0581-z
10
PanagiotouEVamvakarisISyrigosNKKotteasE. Pulmonary benign metastasizing leiomyoma: A case report. Monaldi Arch Chest Dis. (2023) 94:A6925. doi: 10.4081/monaldi.2023.2411
11
AlQudahMAHamouriSHaddadHKTawalbehRHaddadHK. Pulmonary benign metastasizing leiomyoma: A report of two cases. Future Sci OA. (2022) 8:FSO814. doi: 10.2144/fsoa-2022-0021
12
AokiKYamamotoTTerauchiRMoriTShiraiTKitawakiJ. Benign metastasizing leiomyoma in femur and thigh with A history of uterine leiomyoma: A case report and literature review. J Obstet Gynaecol Res. (2021) 47:812–7. doi: 10.1111/jog.14545
13
LiYXuTWangMJiangLLiuQLiuK. Concurrent benign metastasizing leiomyoma in the abdominal wall and pelvic cavity: A case report and review of the literature. Front Surg. (2022) 9:842707. doi: 10.3389/fsurg.2022.842707
14
XiaoHLiBLiWFengXWuL. A rare case of benign abdominal wall and pelvic metastasizing leiomyomas following hysterectomy. J Obstet Gynaecol. (2012) 32:198–9. doi: 10.3109/01443615.2011.622059
15
ZhaoLJiangRLiSGuiQWangZYangY. Clinicopathological study of 6 cases of benign metastasizing leiomyoma. Chin J Clin Exp Pathol. (2017) 33:529–33. doi: 10.13315/j.cnki.cjcep.2017.05.013
16
KapilaKMallikMKAmangunoHGAhmedA. Fine needle aspiration diagnosis of a benign metastasizing leiomyoma of the abdominal wall. J Cytology. (2008) 25:105–7. doi: 10.4103/0970-9371.44047
17
SchwarzEIRamachCMendeKAStrobelK. Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET/CT imaging. Clin Nucl Med. (2009) 34:249–50. doi: 10.1097/RLU.0b013e31819a208f
18
LiangQLingMYuH. The imaging findings and literature of 4 cases with pulmonary benign metastasizing leiomyoma. J Clin Radiol. (2019) 38:746–50. doi: 10.13437/j.cnki.jcr.2019.04.042
19
GosaviAShahSPurandareNCPuranikAAgrawalARangarajanV. Benign metastasizing leiomyoma and findings on fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography. Indian J Nucl Med. (2022) 37:68–70. doi: 10.4103/ijnm.ijnm_118_21
20
AğaçkiranYFindikGUstünLNAydoğduKKayaS. Pulmonary benign metastasizing leiomyoma: an extremely rare case. Turk Patoloji Derg. (2014) 32:193–5. doi: 10.5146/tjpath.2013.01217
21
CaiALiLTanHMoYZhouY. Benign metastasizing leiomyoma. Case report and review of the literature. Herz. (2014) 39:867–70. doi: 10.1007/s00059-013-3904-1
22
PittsSObersteinEMGlassbergMK. Benign metastasizing leiomyoma and lymphangioleiomyomatosis: sex-specific diseases? Clin Chest Med. (2004) 25:343–60. doi: 10.1016/j.ccm.2004.01.014
23
MillerJShoniMSiegertCLebenthalAGodleskiJMcNameeC. Benign metastasizing leiomyomas to the lungs: an institutional case series and a review of the recent literature. Ann Thorac Surg. (2016) 101:253–8. doi: 10.1016/j.athoracsur.2015.05.107
24
YuanXSunYJinYXuLDaiHWangJet al. Multiple organ benign metastasizing leiomyoma: A case report and literature review. J Obstet Gynaecol Res. (2019) 45:2132–6. doi: 10.1111/jog.14066
25
SawaiYShimizuTYamanakaYNikiMNomuraS. Benign metastasizing leiomyoma and 18-FDG-PET/CT: A case report and literature review. Oncol Lett. (2017) 14:3641–6. doi: 10.3892/ol.2017.6609
26
MulitaFTavlasPMaroulisI. A giant ovarian mass in a 68-year-old female with persistent abdominal pain and elevated serum CA-125 level. Prz Menopauzalny. (2020) 19:108–10. doi: 10.5114/pm.2020.97870
27
MulitaFOikonomouNTchabashviliLLiolisEKehagiasI. A giant ovarian mucinous tumor in a 58-year-old postmenopausal patient with persistent abdominal pain and high serum levels of CA 19-9. Pan Afr Med J. (2020) 37:76. doi: 10.11604/pamj.2020.37.76.25932
28
MulitaFLiolisEKehagiasDTchabashviliLKaplanisCIliopoulosFet al. An Enormous Pelvic Tumor in a 46-year-old Woman with an Elevated Serum CA 125 level, What Lies Beneath it? Investigation of Uterine Tumors in Postmenopausal Women. Prz Menopauzalny. (2021) 20:154–7. doi: 10.5114/pm.2021.109773
29
MulitaFIliopoulosFPlachouriKMKehagiasI. Uterine leiomyoblastoma. BMJ Case Rep. (2021) 14:e241533. doi: 10.1136/bcr-2020-241533
30
LewisEIChasonRJDeCherneyAHArmstrongAElkasJVenkatesanAM. Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review. Fertil Steril. (2013) 99:2017–24. doi: 10.1016/j.fertnstert.2013.01.147
31
ZongDHeWLiJPengHChenPOuyangR. Concurrent benign metastasizing leiomyoma in the lung and lumbar spine with elevated standardized uptake value level in positron-emission tomography computed tomography: A case report and literature review. Med (Baltimore). (2018) 97:e11334. doi: 10.1097/MD.0000000000011334
Summary
Keywords
benign metastasizing leiomyoma, myomectomy, abdominal wall, smooth muscle cell, CEUS
Citation
Hu J, Tian S, Pan Q and Yu Y (2024) Multiple benign metastasizing leiomyoma in the abdominal wall: a case report and literature review. Front. Oncol. 14:1391850. doi: 10.3389/fonc.2024.1391850
Received
26 February 2024
Accepted
06 May 2024
Published
17 May 2024
Volume
14 - 2024
Edited by
Andrea Tinelli, Veris delli Ponti Hospital, Italy
Reviewed by
Nasuhi Engin Aydin, Izmir Kâtip Çelebi University, Türkiye
Francesk Mulita, General University Hospital of Patras, Greece
Updates
Copyright
© 2024 Hu, Tian, Pan and Yu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yonghong Yu, yuyonghong8379@126.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.